Gene transfer to ankyrin-deficient bone marrow corrects spherocytosis in vitro

Experimental Hematology

Volumn 28, Issue 7, 2000, Pages 765-774

  Dooner, Gerri J ^a   Barker, Jane E ^b   Gallagher, Patrick G ^c   Debatis, Michelle E ^a   Brown, Agneta H ^a   Forget, Bernard G ^c   Becker, Pamela S ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b JACKSON LABORATORY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Erythrocyte membrane; Erythropoiesis; Gene therapy; Hereditary spherocytosis; Normoblastosis

Indexed keywords

ANKYRIN; COMPLEMENTARY DNA; RECOMBINANT ERYTHROPOIETIN;

ANIMAL CELL; ARTICLE; BONE MARROW; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MATURATION; CELL STRAIN 3T3; CONTROLLED STUDY; ERYTHROBLAST; ERYTHROCYTE DISORDER; ERYTHROCYTE MEMBRANE; ERYTHROID CELL; ERYTHROLEUKEMIA CELL; EXPRESSION VECTOR; GENE TRANSFER; GENETIC TRANSDUCTION; IMMUNOFLUORESCENCE; MOUSE; MUTANT; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; SPLEEN CELL; STEM CELL; WESTERN BLOTTING;

ANIMALS; ANKYRINS; BLOTTING, WESTERN; BONE MARROW; CELL LINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ERYTHROPOIETIN; GENE THERAPY; GENE TRANSFER TECHNIQUES; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; MICE, INBRED BALB C; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPHEROCYTOSIS, HEREDITARY;

MURINAE;

EID: 0034089136     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00185-5     Document Type: Article

References (51)

1. Agre P., Orringer E.P., Bennett V. Deficient red-cell spectrin in severe, recessively inherited spherocytosis. N Engl J Med. 306:1982;1155.
2. Becker P.S., Lux S.E. Disorders of the red cell membrane skeleton. hereditary spherocytosis and hereditary elliptocytosis Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The molecular and metabolic bases of inherited disease. 7th ed:1995;McGraw-Hill, New York. 3513.p.
3. Peters L.L., Lux S.E. Ankyrins. structure and function in normal cells and hereditary spherocytes Sem Hematol. 30:1993;85.
4. Kordeli E., Bennett V. Distinct ankyrin isoforms at neuron cell bodies and nodes of Ranvier resolved using erythrocyte ankyrin-deficient mice. J Cell Biol. 114:1991;1243.
5. Bennett V., Stenbuck P.J. The membrane attachment protein for spectrin is associated with band 3 in human erythrocyte membranes. Nature. 280:1979;468.
6. Bennett V., Stenbuck P.J. Identification and partial purification of ankyrin, the high affinity membrane attachment site for human erythrocyte spectrin. J Biol Chem. 254:1979;2533.
7. Bennett V., Stenbuck P.J. Human erythrocyte ankyrin. Purification and properties. J Biol Chem. 255:1980;2540.
8. Bennett V., Stenbuck P.J. Association between ankyrin and the cytoplasmic domain of band 3 isolated from human erythrocyte membrane. J Biol Chem. 255:1980;6424.
9. Bennett V. Purification of an active proteolytic frament of the membrane attachment site for human erythrocyte spectrin. J Biol Chem. 253:1978;2292.
10. Hargreaves W.R., Giedd K.N., Verkleij A.et al. Reassociation of ankyrin with band 3 in erythrocyte membranes and in lipid vesicles. J Biol Chem. 255:1980;11965.
11. Luna E.J., Kidd G.H., Branton D. Identification by peptide analysis of the spectrin-binding protein in human erythrocytes. J Biol Chem. 254:1979;2526.
12. Lux S.E., John K.M., Bennett V. Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins. Nature. 344:1990;36.
13. Lambert S., Yu H., Prchal J.T., Lawler J.et al. cDNA sequence for human erythrocyte ankyrin. Proc Natl Acad Sci U S A. 87:1990;1730.
14. Weaver D.C., Marchesi V.T. The structural basis of ankyrin function. I. Identification of two structural domains. J Biol Chem. 259:1984;6170.
15. Wallin R., Culp E.N., Coleman D.B.et al. A structural model of human erythrocyte band 2.1. alignment of chemical and functional domains Proc Natl Acad Sci U S A. 81:1984;4095.
16. Platt O.S., Lux S.E., Falcone J.F. A highly conserved region of human erythrocyte ankyrin contains the capacity to bind spectrin. J Biol Chem. 268:1993;24421.
17. Davis L.H., Otto E., Bennett V. Specific 33-residue repeat(s) of erythrocyte ankyrin associate with the anion exchanger. J Biol Chem. 266:1991;11163.
18. Michaely P., Bennett V. The ANK repeats of erythrocyte ankyrin form two distinct but cooperative binding sites for the erythrocyte anion exchanger. J Biol Chem. 270:1995;22050.
19. Kennedy S.P., Warren S.L., Forget B.G. Ankyrin binds to the 15th repetitive unit of erythroid and nonerythroid β-spectrin. J Cell Biol. 115:1991;267.
20. Gallagher P.G., Tse W.T., Scarpa A.L.et al. Large number of alternatively spliced isoforms of the regulatory region of human erythrocyte ankyrin. Trans Assoc Am Phys. 105:1992;268.
21. Davis L.H., Davis J.Q., Bennett V. Ankyrin regulation. an alternatively spliced segment of the regulatory domain functions as an intramolecular regulator J Biol Chem. 267:1992;18996.
22. Wickrema A., Koury S.T., Dai C.H.et al. Changes in cytoskeletal proteins and their mRNAs during maturation of human erythroid progenitor cells. J Cell Physiol. 160:1994;417.
23. Eber S., Lux M.L., Gonzalez J.M.et al. Discovery of 8 ankyrin mutations in hereditary spherocytosis (HS) indicates that ankyrin defects are a major cause of dominant and recessive HS. Blood. 82:1996;309a.
24. Jarolim P., Brabec V., Lambert S.et al. A dominantly inherited mutation of the regulatory domain of ankyrin associated with hereditary spherocytosis. Blood. 76:1990;37a. (abstr).
25. Jarolim P., Rubin H.L., Brabec V.et al. A nonsense mutation 1669Glu → Ter within the regulatory domain of human erythroid ankyrin leads to a selective deficiency of the major ankyrin isoform (band 2.1) and a phenotype of autosomal dominant hereditary spherocytosis. J Clin Invest. 95:1995;941.
26. Hayette S., Carre G., Bozon M.et al. Two distinct truncated variants of ankyrin associated with hereditary spherocytosis. Am J Hematol. 58:1998;36.
27. Eber S.W., Gonzalez J.M., Lux M.L.et al. Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis. Nat Genet. 13:1996;214.
28. Miraglia del Guidice E., Hayette S., Bozon M.et al. Ankyrin Napoli. a de novo deletional frameshift mutation in exon 16 of ankyrin gene (ANK1) associated with spherocytosis Br J Haematol. 93:1996;828.
29. Morle L., Bozon M., Alloisio N.et al. Ankyrin bugey. a de novo deletional frameshift variant in exon 6 of the ankyrin gene associated with spherocytosis Am J Hematol. 54:1997;242.
30. Randon J., Miraglia del Guidice E., Bozon M.et al. Frequent de novo mutations of the ANK1 gene mimic a recessive mode of transmission in hereditary spherocytosis. three new ANK1 variants: Ankyrins Bari, Napoli II and Anzio Br J Haematol. 96:1997;500.
31. Bernstein S.E. Inherited hemolytic disease in mice. a review and update Lab Anim Sci. 30:1980;197.
32. Bodine D.M., Birkenmeier C.S., Barker J.E. Spectrin deficient inherited hemolytic anemias in the mouse. characterized by spectrin synthesis and mRNA in reticulocytes Cell. 37:1984;721.
33. Rybicki A.C., Musto S., Schwartz R.S. Decreased content of protein 4.2 in ankyrin-deficient normoblastosis (nb/nb) mouse red blood cells. evidence for ankyrin enhancement of protein 4.2 membrane binding Blood. 86:1995;3583.
34. Yi S.J., Liu S.C., Derick L.H.et al. Red cell membranes of ankyrin-deficient nb/nb mice lack band 3 tetramers but contain normal membrane skeletons. Biochem. 36:1997;9596.
35. White R.A., Birkenmeier C.S., Lux S.E.et al. Ankyrin and the hemolytic anemia mutation, nb, map to mouse chromosome 8. Presence of the nb allele is associated with a truncated ankyrin Proc Natl Acad Sci U S A. 87:1990;3117.
36. Peters L.L., Birkenmeier C.S., Bronson R.T.et al. Purkinje cell degeneration associated with erythroid ankyrin deficiency in nb/nb mice. J Cell Biol. 114:1991;1233.
37. Peters L.L., Turtzo L.C., Birkenmeier C.S.et al. Distinct fetal Ank-1 and Ank-2 related proteins and mRNAs in normal and nb/nb mice. Blood. 81:1993;2144.
38. Gallagher P.G., Romana M., Tse W.T.et al. Erythroid-specific expression of the human erythrocyte ankyrin gene is mediated by a promoter that displays features found in both housekeeping and erythroid gene promoters. Blood. 84:1994;361a. (abstr).
39. Gallagher P.G., Sabatino D.E., Garrett L.J.et al. Expression of the human ankyrin. 1(ANK1 gene in vitro and in vivo is mediated by a promoter that requires GATA-1 and CACCC-binding proteins for its activity Blood 92):1998;7a. (abstr).
40. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156.
41. Cone R.D., Weber-Benarous A., Baorto D.et al. Regulated expression of a complete human beta-globin gene encoded by a transmissible retrovirus vector. Mol Cell Biol. 7:1987;887.
42. Bahnson A.B., Dunigan J.T., Baysal B.E.et al. Centrifugal enhancement of retroviral mediated gene transfer. J Virol Meth. 54:1995;131.
43. Patel V.P., Lodish H.F. A fibronectin matrix is required for differentiation of murine erythroleukemia cells into reticulocytes. J Cell Biol. 105:1987;3105.
44. Spangrude G.J., Scollay R. A simplified method for enrichment of mouse hematopoietic stem cells. Exp Hematol. 18:1990;920.
45. Bertoncello I., Bradley T.R., Watt S.M. An improved negative immunomagnetic selection strategy for the purification of primitive hemopoietic cells from normal bone marrow. Exp Hematol. 19:1991;95.
46. Panzenbock B., Bartunek P., Mapara M.Y.et al. Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro. Blood. 92:1998;3658.
47. Challita P.M., Kohn D.B. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci U S A. 91:1994;2567.
48. Barklis E., Mulligan R.C., Jaenisch R. Chromosomal position of virus mutation permits retrovirus expression in embryonal carcinoma cells. Cell. 47:1986;391.
49. Sabatino D.E., Cline A.P., Gallagher P.G.et al. Substitution of the human beta-spectrin promoter for the human A gamma-globin promoter prevents silencing of a linked human beta-globin gene in transgenic mice. Mol Cell Biol. 18:1998;6634.
50. Seidel N.E., Sabatino D.E., Cline A.P.et al. Retrovirus vectors containing the ankyrin promoter fused to a human A-gamma globin gene are stable when transduced into mouse hematopoietic stem cells and express gamma globin mRNA at levels which are approximately 2-6% of total mouse alpha globin mRNA. Blood. 94(suppl. 1):1999;176a. (abstr).
51. White R.A., Birkenmeier C.S., Peters L.L.et al. Murine erythrocyte ankyrin cDNA. highly conserved regions of the regulatory domain Mamm Genome. 3:1992;281.